Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the NYSE in New York (Reuters) - Johnson & Johnson ...

Johnson & Johnson’s top executive should be forced to testify about claims that the company illegally marketed the antipsychotic drug Risperdal, which allegedly caused boys to grow breasts, lawyers ...

Johnson & Johnson, still reeling from settling two Ohio opioid-related lawsuits for more than $20 million, was slapped with an $8 billion judgment on Tuesday over its antipsychotic drug Risperdal. A ...

When regular citizens get together in the civil justice system to deliberate difficult claims about complex matters, they may not get everything just right to the satisfaction of the disputing parties ...

The FDA told Johnson & Johnson (JNJ) in 1997 that its request to market the antipsychotic drug Risperdal for children was "without any justification." In the following years, J&J's army of ...

A judge on Friday took an axe to a legal award against Johnson & Johnson — chopping the settlement from $8 billion to $6.8 million — in the case of a man who said the company failed to warn consumers ...

Johnson & Johnson swung to a first-quarter loss as the company took a charge from an acquisition and felt the impact of challenges to some of its prescription drug and device franchises. First-quarter ...

A Philadelphia judge shaved $1.2 billion off the amount Johnson & Johnson has to pay in a lawsuit over the marking of its antipsychotic drug, Risperdal, The New York Times reported. In October, a jury ...